Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Clinical Pharmacology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Clinical Pharmacology
    Escitalopram Decreases Symptoms of Major Depressive Disorder in Adolescents: Presented at AACAP - (DGDispatch)
    Cetuximab Continues to Increase Survival in Patients With Head and Neck Cancer for Up to 5 Years - (DGNews)
    Indacaterol Produces Effective Bronchodilation in Patients With COPD During 1 Year of Treatment: Presented at CHEST 2009 - (DGDispatch)
    FDA Approves Romidepsin Injection for Previously Treated T-Cell Lymphoma - (DGNews)
    Long-Term Treatment With Tiotropium Is Effective for Men, Women With COPD: Presented at CHEST 2009 - (DGDispatch)

    News archive

     Recent webcasts/CME - Clinical Pharmacology
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Insulin-Dependent Diabetes in Long-Term Care: Practical Considerations
    • Patient-Centered Approaches to the Evaluation and Management of Atrial Fibrillation
      Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment

      Webcasts/CME archive

       Recent cases - Clinical Pharmacology
        Rapid and Persistent Selection of the K103N Mutation as a Majority Quasispecies in a HIV1-Patient Exposed to Efavirenz for Three Weeks: A Case Report and Review of the Literature
        Reversible Cerebellar Syndrome Caused by Metronidazole
        Complete Remission of Severe Idiopathic Cold Urticaria on Interleukin-1 Receptor Antagonist (Anakinra)
        Rapid Resolution of Nitrofurantoin-Induced Interstitial Lung Disease
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report

        Cases archive
          




        my personal edition > clinical pharmacology > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Case Report: Mirtazapine Associated With Hypertriglyceridaemia, Acute Pancreatitis And Diabetic Ketoacidosis

        A DGReview of :"Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report"
        Pharmacotherapy

        08/13/2003
        By Keely S Solomon, PhD


        Mirtazapine therapy may have caused hypertriglyceridaemia, acute pancreatitis and diabetic ketoacidosis in a 44-year old Caucasian woman, according to a recent case report from The University Hospital for the Albert Einstein College of Medicine, United States.

        Mirtazapine is an antidepressant with a tetracyclic structure. Both acute pancreatitis and new-onset diabetes have been reported as possible adverse effects in early clinical trials. However, only 3 sub-clinical cases of possible mirtazapine-induced pancreatitis have been published, all without concurrent diabetes complications.

        Julie L. Chen, Pharm.D., and colleagues have reported a case of a woman admitted with severe epigastric pain after taking mirtazapine (45 mg/day) for two months. She had a medical history of major depression and obsessive-compulsive disorder.

        The patient was obese (BMI, 43.7 kg/m2), and laboratory tests revealed elevated serum triglycerides (2055 mg/dL), serum amylase (478 U/L) and lipase (1059 U/L) levels. White blood cell count, glucose, aspartate aminotransferase and alanine aminotransferase were also elevated, and an increased anion gap metabolic acidosis was detected. Urinalysis was positive for ketones and glucose.

        The patient was diagnosed with acute pancreatitis with concurrent diabetic ketoacidosis. A drug-induced therapy was suspected after other possible causes of acute pancreatitis, such as excessive alcohol consumption or gallstones, were ruled out.

        Mirtazapine was specifically suspected because it was the only drug recently started. Oral gemflibrozil (600 mg twice/day) was initiated, together with other supportive care, and all of the patient's previous drugs except mirtazapine were restarted.

        After 3 days, serum amylase and lipase levels returned to normal and the abdominal pain resolved. Serum triglycerides continued to improve during the 17-day hospitalisation, and the acute pancreatitis and diabetes were resolving at the time of discharge. Two months later, cholesterol and triglyceride levels were 194 and 101 mg/dL, respectively, serum amylase and lipase levels were within the normal range, and the diabetes was under good control.

        The researchers advise that, "health care providers should be aware of these possible serious complications associated with mirtazapine therapy." For patients receiving this treatment, they recommend, "serum glucose and lipid levels, and especially triglycerides, should be measured at baseline and monitored regularly thereafter."
        Pharamcotherapy 2003;23:7:940-944. "Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send